We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+4.59%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$94.2M
AUM Growth
+$7.66M
Cap. Flow
+$4.36M
Cap. Flow %
4.62%
Top 10 Hldgs %
41.69%
Holding
106
New
19
Increased
31
Reduced
29
Closed
25

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.36M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.19M
3
BABA icon
Alibaba
BABA
+$1.84M
4
CRM icon
Salesforce
CRM
+$1.69M
5
DIS icon
Walt Disney
DIS
+$1.65M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$1.9M
2
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$1.43M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$1.16M
4
AMZN icon
Amazon
AMZN
+$1.09M
5
LYV icon
Live Nation Entertainment
LYV
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 43.57%
2 Technology 14.03%
3 Communication Services 6.74%
4 Consumer Discretionary 5.25%
5 Financials 3.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
51
CALL
Amgen
AMGN
$222B
$553K 0.59%
+3,000
New +$537K
FICO icon
52
Fair Isaac
FICO
$22.5B
$553K 0.59%
1,761
-967
-35% -$280K
NTGN
53
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$491K 0.52%
103,596
-255,529
-71% -$1.43M
DBX icon
54
Dropbox
DBX
$8.12B
$475K 0.5%
18,959
-17,783
-48% -$411K
CTLT
55
DELISTED
CATALENT, INC.
CTLT
$431K 0.46%
+7,952
New +$364K
WMGI
56
DELISTED
Wright Medical Group Inc
WMGI
$423K 0.45%
14,180
+3,123
+28% +$95.3K
XNTK icon
57
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
$395K 0.42%
4,500
-27,000
-86% -$1.95M
THC icon
58
Tenet Healthcare
THC
$21.1B
$394K 0.42%
+19,048
New +$439K
PBYI icon
59
Puma Biotechnology
PBYI
$454M
$350K 0.37%
27,567
+74
+0.3% +$1.7K
MMSI icon
60
Merit Medical Systems
MMSI
$5.32B
$346K 0.37%
5,813
-5,816
-50% -$334K
PCRX icon
61
Pacira BioSciences
PCRX
$997M
$317K 0.34%
7,291
+4,118
+130% +$175K
VYGR icon
62
Voyager Therapeutics
VYGR
$198M
$312K 0.33%
11,444
+1,308
+13% +$29.9K
DERM
63
DELISTED
Dermira, Inc.
DERM
$291K 0.31%
30,429
+15,172
+99% +$163K
RVTY icon
64
Revvity
RVTY
$12.8B
$290K 0.31%
3,010
-3,914
-57% -$365K
CHRS icon
65
Coherus Oncology
CHRS
$196M
$279K 0.3%
12,607
+4,493
+55% +$78K
UNH icon
66
UnitedHealth
UNH
$370B
$275K 0.29%
1,125
-7,910
-88% -$1.9M
ICLR icon
67
Icon
ICLR
$12.7B
$259K 0.28%
+1,679
New +$235K
FATE icon
68
Fate Therapeutics
FATE
$326M
$250K 0.27%
12,328
+4,456
+57% +$80.3K
AVTR icon
69
Avantor
AVTR
$9.19B
$228K 0.24%
+11,964
New +$213K
CSII
70
DELISTED
Cardiovascular Systems, Inc.
CSII
$218K 0.23%
5,072
+602
+13% +$23.4K
LAB icon
71
Standard BioTools
LAB
$314M
$175K 0.19%
14,221
-403
-3% -$5.13K
QURE icon
72
uniQure
QURE
$3.22B
$153K 0.16%
1,961
-1,450
-43% -$92.4K
INGN icon
73
Inogen
INGN
$164M
$124K 0.13%
+1,852
New +$141K
CRWD icon
74
CrowdStrike
CRWD
$218B
$118K 0.13%
+6,920
New +$118K
KRTX
75
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$116K 0.12%
+7,219
New +$145K
1 2
3
4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Partner Investment Management held 106 positions worth $94.2M, up 8.9% from $86.5M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Partner Investment Management deployed $4.36M of net new capital in Q2 2019, opening 19 new positions and adding to 31 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 25,610 shares worth $2.19M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was UnitedHealth, an estimated $1.9M trimmed.

  • Partner Investment Management's largest Q2 2019 buy was BioMarin Pharmaceuticals: 25,610 shares worth $2.19M.
  • Partner Investment Management added most to Allergan plc in Q2 2019, an estimated $2.36M increase.
  • Partner Investment Management's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $1.9M.
  • Partner Investment Management fully exited Amazon in Q2 2019, selling an estimated $1.09M.
  • Partner Investment Management's ten largest holdings make up 42% of its $94.2M portfolio in Q2 2019.
  • Partner Investment Management opened 19 new positions and closed 25 in Q2 2019.
  • Partner Investment Management's portfolio value rose 8.9% quarter-over-quarter to $94.2M.

Based on Partner Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.